Suzhou Wuzhong Pharmaceutical

Jiangsu Wuzhong Pharmaceutical is a prominent Chinese pharmaceutical group headquartered in Suzhou, specializing in the research, development, and manufacturing of a wide range of medical products. Historically focused on anti-infectives, cardiovascular, and oncology drugs, the company has recently undergone a strategic transformation to become a leader in the medical aesthetics sector. It is notably the exclusive distributor of the PDLLA filler AestheFill in mainland China and is aggressively developing a proprietary recombinant humanized collagen pipeline. The company is listed on the Shanghai Stock Exchange and maintains multiple GMP-certified manufacturing bases to support its diverse portfolio of chemical drugs and biological products.